Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Sep;83(1):259–269. doi: 10.1111/j.1476-5381.1984.tb10142.x

Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine.

G C Kirby, D S McQueen
PMCID: PMC1987184  PMID: 6487893

Abstract

The effects of intracarotid (i.c.) injections of 5-hydroxytryptamine (5-HT; 1-50 micrograms) on carotid chemoreceptor activity recorded from the carotid sinus nerve have been studied in anaesthetized cats. Three separate components in the complex response of the chemoreceptors to injected 5-HT were identified. Firstly, a transient burst of activity was obtained during the injection period in 56% of the recordings. Secondly, in all the recordings a period of chemodepression commenced a few seconds after completing the injection and was usually dose-related. Thirdly, a delayed longer-lasting chemoexcitation occurred in many experiments, concomitant with a fall in systemic blood pressure. The neuronal 5-HT receptor antagonist MDL 72222 (10-100 micrograms kg-1, i.c.) virtually abolished the transient chemoexcitation evoked during 5-HT injections and also significantly increased the mean ID50 for 5-HT-induced chemodepression; in 37% of recordings 5-HT caused a dose-related chemoexcitation after the high dose of MDL 72222. Neither the delayed chemoexcitation nor the hypotension caused by 5-HT were much affected by the antagonist. MDL 72222 itself had a biphasic effect on chemosensory discharge, causing depression followed by a delayed excitation. The 5-HT2-receptor antagonist ketanserin (100 micrograms kg-1, i.c.) had no appreciable effect on the transient chemoexcitation evoked during 5-HT injections and caused a slight but significant increase in the mean ID50 for 5-HT-induced chemodepression. The delayed chemoexcitation and accompanying hypotension associated with 5-HT were both substantially reduced or abolished by the antagonist. Ketanserin itself caused a short-lasting period of chemoexcitation. All the effects of injected 5-HT on chemosensory discharge could be abolished by the combination of MDL 72222 and ketanserin (100 micrograms kg-1, i.c.). Neither MDL 72222 nor ketanserin had any significant effect upon the response of the carotid chemoreceptors to hypoxia. The rate at which discharge increased, and also the steady-state discharge before and during hypoxia, were unaffected by the antagonists, alone or in combination. At least two types of 5-HT receptor appeared to be involved in the response of carotid body chemoreceptors to 5-HT. Transient excitation and chemodepression were mediated via MDL 72222-sensitive (peripheral neuronal) receptors whereas the delayed chemoexcitation and associated hypotension involved a ketanserin-sensitive, presumably 5-HT2-, receptor. It appears unlikely that 5-HT plays a crucial role in chemoreception.

Full text

PDF
259

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black A. M., Comroe J. H., Jr, Jacobs L. Species difference in carotid body response of cat and dog to dopamine and serotonin. Am J Physiol. 1972 Nov;223(5):1097–1102. doi: 10.1152/ajplegacy.1972.223.5.1097. [DOI] [PubMed] [Google Scholar]
  2. COMROE J. H., Jr, VAN LINGEN B., STROUD R. C., RONCORONI A. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol. 1953 Jun;173(3):379–386. doi: 10.1152/ajplegacy.1953.173.3.379. [DOI] [PubMed] [Google Scholar]
  3. Chiocchio S. R., Biscardi A. M., Tramezzani J. H. 5-hydroxytryptamine in the carotid body of the cat. Science. 1967 Nov 10;158(3802):790–791. doi: 10.1126/science.158.3802.790. [DOI] [PubMed] [Google Scholar]
  4. Cuello A. C., McQueen D. S. Substance P: a carotid body peptide. Neurosci Lett. 1980 Apr;17(1-2):215–219. doi: 10.1016/0304-3940(80)90087-7. [DOI] [PubMed] [Google Scholar]
  5. DOUGLAS W. W., TOH C. C. The respiratory stimulant action of 5-hydroxytryptamine (serotonin) in the dog. J Physiol. 1953 May 28;120(3):311–318. doi: 10.1113/jphysiol.1953.sp004896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Docherty R. J., McQueen D. S. Inhibitory action of dopamine on cat carotid chemoreceptors. J Physiol. 1978 Jun;279:425–436. doi: 10.1113/jphysiol.1978.sp012354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Eyzaguirre C., Nishi K. Further study on mass receptor potential of carotid body chemosensors. J Neurophysiol. 1974 Jan;37(1):156–169. doi: 10.1152/jn.1974.37.1.156. [DOI] [PubMed] [Google Scholar]
  8. Fozard J. R. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn Schmiedebergs Arch Pharmacol. 1984 May;326(1):36–44. doi: 10.1007/BF00518776. [DOI] [PubMed] [Google Scholar]
  9. GINZEL K. H., KOTTEGODA S. R. The action of 5-hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat. J Physiol. 1954 Feb 26;123(2):277–288. doi: 10.1113/jphysiol.1954.sp005050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. GYERMEK L. 5-hydroxytryptamine antagonists. Pharmacol Rev. 1961 Sep;13:399–439. [PubMed] [Google Scholar]
  11. Grönblad M., Liesi P., Rechardt L. Serotonin-like immunoreactivity in rat carotid body. Brain Res. 1983 Oct 16;276(2):348–350. doi: 10.1016/0006-8993(83)90745-x. [DOI] [PubMed] [Google Scholar]
  12. Hökfelt T., Johansson O., Ljungdahl A., Lundberg J. M., Schultzberg M. Peptidergic neurones. Nature. 1980 Apr 10;284(5756):515–521. doi: 10.1038/284515a0. [DOI] [PubMed] [Google Scholar]
  13. Kebabian J. W., Calne D. B. Multiple receptors for dopamine. Nature. 1979 Jan 11;277(5692):93–96. doi: 10.1038/277093a0. [DOI] [PubMed] [Google Scholar]
  14. Leysen J. E., Awouters F., Kennis L., Laduron P. M., Vandenberk J., Janssen P. A. Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci. 1981 Mar 2;28(9):1015–1022. doi: 10.1016/0024-3205(81)90747-5. [DOI] [PubMed] [Google Scholar]
  15. MAJNO G., PALADE G. E. Studies on inflammation. 1. The effect of histamine and serotonin on vascular permeability: an electron microscopic study. J Biophys Biochem Cytol. 1961 Dec;11:571–605. doi: 10.1083/jcb.11.3.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MOTT J. C., PAINTAL A. S. The action of 5-hydroxytryptamine on pulmonary and cardiovascular vagal afferent fibres and its reflex respiratory effects. Br J Pharmacol Chemother. 1953 Jun;8(2):238–241. doi: 10.1111/j.1476-5381.1953.tb00786.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McQueen D. S. A quantitative study of the effects of cholinergic drugs on carotid chemoreceptors in the cat. J Physiol. 1977 Dec;273(2):515–532. doi: 10.1113/jphysiol.1977.sp012107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nishi K. The action of 5-hydroxytryptamine on chemoreceptor discharges of the cat's carotid body. Br J Pharmacol. 1975 Sep;55(1):27–40. doi: 10.1111/j.1476-5381.1975.tb07606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. PAGE I. H. The vascular action of natural serotonin, 5- and 7-hydroxytryptamine and tryptamine. J Pharmacol Exp Ther. 1952 May;105(1):58–73. [PubMed] [Google Scholar]
  20. Steele R. H., Hinterberger H. Catecholamines and 5-hydroxytryptamine in the carotid body in vascular, respiratory, and other diseases. J Lab Clin Med. 1972 Jul;80(1):63–70. [PubMed] [Google Scholar]
  21. Wallis D. Neuronal 5-hydroxytryptamine receptors outside the central nervous system. Life Sci. 1981 Dec 7;29(23):2345–2355. doi: 10.1016/0024-3205(81)90470-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES